arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

DYADIC INTERNATIONAL INC

DYAI
$0.34 ▼ -0.02 (-6.18%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
10 Visible periods
25 Metrics
Peer-ranked Benchmarks
Price Chart
19
Health
Poor
Bearish
auto_awesome

Analytical Summary

DYADIC INTERNATIONAL INC faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap —
Dividend Yield —
Revenue Growth -11.6% ↘
Op. Margin -232.8% ↘
ROIC -461.1% ↘
FCF / Share None
Trailing P/E —
Price / Book 10.0x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

10-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$3.09M
↓ -11.6% —
Net Income Profit after all expenses
$-7.36M
↓ -26.8% —
Operating Margin Operating profit as % of sales
-232.8%
↓ -37.9% 0th
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
1
Financial Health ↑
25
Cash Quality ↓
52

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 10 years · 36 quarters